Viz SDH

by Viz.ai  · Based in United States → — The proven AI-powered care coordination platform
Emergency Medicine Neurosurgery Radiology

Enterprise (hospital/health system)
Regulatory Status Disclosed

Overview

Viz SDH is an artificial intelligence (AI) powered tool developed by Viz.ai, designed for the automatic detection of subdural hemorrhage (SDH) in non-contrast CT images of the head. It identifies both acute and chronic subdural bleeds, enabling physicians to effectively triage patients and deliver optimal care. The system operates as a notification-only, parallel workflow tool, analyzing images and sending alerts to appropriate medical specialists, such as neurovascular specialists or neurosurgeons, independent of the standard of care workflow. This facilitates faster assessment and communication among care teams, aiming to improve patient outcomes by expediting diagnosis and treatment pathways for time-critical conditions.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automatic AI detection of acute and chronic subdural hemorrhage on non-contrast CT images.
  • Real-time notification to neurovascular or neurosurgical specialists.
  • Mobile application for receiving alerts and previewing images (for informational purposes).
  • Quantification of subdural collections, including volume, thickness, and midline shift (available with Viz SDH+ module).
  • Integration into existing clinical workflows (e.g., radiology workflow, mobile, web).
  • Supports image sharing and communication among care teams.

Use Cases

  • Expediting diagnosis and treatment pathways for subdural hematomas.
  • Improving care coordination and communication among multidisciplinary care teams.
  • Triage and prioritization of patients with suspected subdural hemorrhage.
  • Facilitating faster, more informed treatment decisions, especially for acute and chronic bleeds.
  • Optimizing emergency healthcare workflows and reducing time to treatment.
  • Supporting guideline-directed interventions for neurovascular diseases.

What Physicians Need to Know

Brain MRI/CT Analysis
Analyzes medical imaging data, including CT scans, delivering real-time insights and automated assessments to accelerate diagnosis.
Large Vessel Occlusion Detection
AI-powered suite of solutions to accelerate the detection and treatment of suspected neurovascular diseases, including Large Vessel Occlusion (LVO).
Mobile Notification System
Real-time communications get connected within seconds of suspected disease—wherever and without delay on a mobile or desktop device. Alerts teams to potential LVOs and allows quick viewing on a phone.
Physician Tip

The platform auto-detects suspected diseases across a wide range of therapeutic areas in seconds, accelerating time to diagnosis and treatment. Real-time communications on mobile or desktop devices allow for immediate team activation and improved patient access to life-saving treatments. The Viz Neuro Suite specifically addresses neurovascular diseases like LVO, Cerebral Aneurysm, and Hemorrhage, providing critical insights from CT Perfusion (CTP) and Hyperdensity Measurements.

Viz.ai is a comprehensive AI-powered care coordination platform with over 50 FDA-cleared AI algorithms. It is designed to integrate with existing workflows to streamline communication and accelerate treatment decisions. The platform is also involved in pilot programs with Microsoft Cloud for Healthcare.

Details

Category Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Enterprise (hospital/health system)
DeploymentCloud-native, integrates with PACS and EHR systems.
Mobile AppYes, for real-time alerts and image viewing.
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
SOC 2 Yes AI-estimated
GDPR Yes AI-estimated
Integrations
EHR Not specified
Specialties Emergency Medicine, Neurosurgery, Radiology

Support & Reliability

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2022-07-25K220439 510(k)Viz SDH

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Viz SDH

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Viz SDH.

View all on YouTube

Frequently Asked Questions

Viz SDH is part of the Viz Neuro Suite, which is an AI-powered suite of solutions designed to accelerate the detection and treatment of suspected neurovascular diseases. The platform uses AI algorithms to analyze medical imaging data, delivering real-time insights to streamline workflows and support faster treatment decisions for conditions like subdural hemorrhage.
The Viz.ai platform features more than 50 FDA-cleared AI algorithms. While the text confirms overall FDA clearance for the platform's algorithms, it does not specify individual clearances for each module like Viz SDH.
The provided text does not specify any known limitations or contraindications for the use of Viz SDH. It highlights the platform's capabilities in accelerating diagnosis and treatment.
Viz.ai emphasizes that its solutions are designed to be smart, simple, and supportive, with dedicated implementation experts. The platform aims to streamline communications and improve patient response by providing real-time communication within seconds of suspected disease detection on mobile or desktop devices.
The provided text focuses solely on Viz.ai's offerings and does not mention or compare Viz SDH to any alternative products or solutions for AI-powered subdural hemorrhage detection.
The provided official website text does not contain any information regarding the pricing model for Viz SDH or the Viz Neuro Suite. To obtain pricing details, one would need to contact Viz.ai directly.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

More from Viz.ai

Viz AAA
Viz.ai
Cardiology AI
ai for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, designed to accelerate diagnosis and care coordination.
Viz ANEURYSM
Viz.ai
Neurology AI
ai that auto-detects suspected cerebral aneurysms in CT angiograms (CTAs), streamlining neurovascular care coordination and facilitating timely patient management.
Viz CTP
Viz.ai
Clinical Decision Support & Reference
Viz.
Viz HCM
Viz.ai
Cardiology AI
ai that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-15 | First Added: 2026-04-19

Investors who backed Viz SDH

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.